Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - valaciclovir hydrochloride, quantity: 556 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; povidone; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; indigo carmine aluminium lake - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash.,for the treatment of ophthalmic zoster.,for the treatment of recurrent herpes labialis (cold sores),for the treatment of clinical episodes of genital herpes simplex infections.,for the prevention of recurrent genital herpes.,reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valaciclovir, it is recommended that patients use safer sex practices. ,prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - valaciclovir hydrochloride, quantity: 1112 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; crospovidone; microcrystalline cellulose; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; indigo carmine aluminium lake - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash.,for the treatment of ophthalmic zoster.,for the treatment of recurrent herpes labialis (cold sores),for the treatment of clinical episodes of genital herpes simplex infections.,for the prevention of recurrent genital herpes.,reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valaciclovir, it is recommended that patients use safer sex practices. ,prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - valaciclovir hydrochloride - oral tablet - 500mg

Canada - English - Health Canada

pharmapar inc - valacyclovir (valacyclovir hydrochloride) - tablet - 500mg - valacyclovir (valacyclovir hydrochloride) 500mg - nucleosides and nucleotides

Canada - English - Health Canada

apotex inc - valacyclovir (valacyclovir hydrochloride) - tablet - 500mg - valacyclovir (valacyclovir hydrochloride) 500mg - nucleosides and nucleotides

Canada - English - Health Canada

pharmascience inc - valacyclovir (valacyclovir hydrochloride) - tablet - 500mg - valacyclovir (valacyclovir hydrochloride) 500mg - nucleosides and nucleotides

Canada - English - Health Canada

pro doc limitee - valacyclovir (valacyclovir hydrochloride) - tablet - 500mg - valacyclovir (valacyclovir hydrochloride) 500mg - nucleosides and nucleotides

Canada - English - Health Canada

laboratoire riva inc. - valacyclovir (valacyclovir hydrochloride) - tablet - 500mg - valacyclovir (valacyclovir hydrochloride) 500mg - nucleosides and nucleotides

Canada - English - Health Canada

mylan pharmaceuticals ulc - valacyclovir (valacyclovir hydrochloride) - tablet - 500mg - valacyclovir (valacyclovir hydrochloride) 500mg - nucleosides and nucleotides

Canada - English - Health Canada

mylan pharmaceuticals ulc - valacyclovir (valacyclovir hydrochloride) - tablet - 1000mg - valacyclovir (valacyclovir hydrochloride) 1000mg - nucleosides and nucleotides